MOLECULAR CHARACTERISTICS AND CLINICAL ASPECTS OF ALPHA 1-ANTITRYPSIN DEFICIENCY
MOLECULAR CHARACTERISTICS AND CLINICAL ASPECTS OF ALPHA 1-ANTITRYPSIN DEFICIENCY
批准号:
6162714
负责人:
J MOSS
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
alpha 1 antitrypsin alpha 1 antitrypsin deficiency asthma bronchodilators clinical research cycloheximide enzyme induction /repression human therapy evaluation immunoglobulin E metabolism disorder chemotherapy molecular pathology patient /disease registry protein degradation respiratory disorder chemotherapy respiratory function
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The mutant Z form of alpha-1-antitrypsin (AAT) is responsible for more
than 95% of all individuals with AAT deficiency, an important inherited
cause of emphysema and liver disease. The Z AAT gene encodes a protein
with a single amino acid change which causes intracellular misfolding.
Since secreted Z AAT is a functional antiprotease, we hypothesized that
interrupting catabolism of retained Z AAT might increase transport of
Z AAT out of cells and allow partial restoration of extracellular
antiprotease protection. Both the protein translation inhibitor
cycloheximide and the specific inhibitor of proteasome function,
lactacystin, prevented intracellular degradation of Z AAT. Moreover,
this inhibition of degradation was associated with partial restoration
of vesicular transport of Z AAT. This effect was observed in a model
system of transfected CHO cells as well as in human alveolar macrophages
synthesizing Z AAT. This study demonstrates that altering the
intracellular fate of a misfolded protein may be an option in the
treatment of diseases associated with misfolded, but potentially
functional proteins. Retention of AAT in the rough endoplasmic
reticulum (RER) appears to be an important step in the arrest of AAT
secretion for several deficiency variants including Z AAT. RER-retained
Z AAT polymerizes via insertion of a reactive site loop (RSL) into the
partially open b sheet A of another Z molecule. Loop-sheet
polymerization may play a role in RER retention of some truncated AAT
proteins. Based on the analysis of AAT and other SERPIN mutants, it has
been proposed that sheet A of these proteins may serve as a "shutter",
which allows the RSL to insert into sheet A, resulting in a structural
change and increased protein stability. We hypothesized that disturbed
packing directly under b sheet A may allow the SERPIN shutter to open
as a prelude to loop-sheet polymerization, RER retention and accelerated
intracellular degradation. To determine whether packing under sheet A
affects conformation of the RSL, protein stability and intracellular
half-life, we used AAT translated in vitro and in CHO cells transfected
with either normal AAT or variants that terminate under b sheet A at
codon 373 or 376, well beyond the RSL.Our results support the hypothesis
that increased polymerization may correlate with SERPIN shutter opening
and insertion of the RSL into b sheet A, when packing beneath the
shutter is disturbed. This polymerization may be one important mechanism
responsible for intracellular retention and accelerated degradation in
some truncated forms of AAT.Neutrophil defensins are highly cytoxic
molecules which compose 30% of the protein weight of neutrophils. They
have a wide spectrum of targets which include bacteria, virus, fungi and
human epithelial cells. Importantly, the cytotoxicity of neutrophil
defensins is abolished by alpha-1-antitrypsin. We have determine that
on the average, there is 10 fold more human neutrophil defensins present
in the epithelial lining fluid of alpha-1-antitrypsin deficient
individuals with mild pulmonary dysfunction than in normals.
Furthermore, we have determined that the amount of neutrophil defensins
correlates with the amount of neutrophil elastase and number of
neutrophils. Recently, we have demonstrated that defensins are cytotoxic
for alveolar macrophages and importantly, stimulate them to release the
powerful chemoattractant LTB4 in amounts 5-fold those from unstimulated
cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZATION OF MAMMALIAN ADP-RIBOSLYTRANSFERASES
-
批准号:2576748
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
CHARACTERIZATION OF THE PATHOGENESIS OF LYMPHANGIOLEIOMYOMATOSIS (LAM)
-
批准号:2441409
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
-
批准号:3857979
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
ROLE OF NITRIC OXIDE IN THE PATHOGENESIS OF LUNG DISEASE
-
批准号:2576802
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
ADP-RIBOSYLATION CYCLES
-
批准号:6162671
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
MOLECULAR CHARACTERISTICS AND CLINICAL ASPECTS OF ALPHA 1-ANTITRYPSIN DEFICIENCY
-
批准号:2576803
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
PATHOGENESIS AND THERAPY OF PULMONARY FIBROSIS
-
批准号:6109234
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
CHARACTERIZATION OF MAMMALIAN ADP-RIBOSLYTRANSFERASES
-
批准号:6162666
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
ROLE OF NITRIC OXIDE IN THE PATHOGENESIS OF LUNG DISEASE
-
批准号:6162713
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
-
批准号:3843260
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
ADP-RIBOSYLATION CYCLES
-
批准号:2576753
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
MOLECULAR CHARACTERISTICS AND CLINICAL ASPECTS OF ALPHA 1-ANTITRYPSIN DEFICIENCY
-
批准号:6109231
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
CHARACTERIZATION OF THE PATHOGENESIS OF LYMPHANGIOLEIOMYOMATOSIS (LAM)
-
批准号:6162716
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
-
批准号:3919996
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
-
批准号:3878894
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
TRANSDUCIN GTPASE--GENES FOR GTP-BINDING PROTEINS
-
批准号:4694497
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE MECHANISMS
-
批准号:4694491
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
-
批准号:3942780
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
-
批准号:3779503
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
REGULATION OF CYCLIC NUCLEOTIDE METABOLISM
-
批准号:3966535
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J MOSS
-
依托单位:
海外基金